Tolerability of veliparib (V) in combination with carboplatin (C)/paclitaxel (P): Based chemoradiotherapy (CRT) in subjects with stage III non-small cell lung cancer (NSCLC).
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: David E. Kozono, Joseph Kamel Salama, Tom Stinchcombe, Jeffrey Bogart, William J. Petty, Michael J. Guarino, Lyudmila Bazhenova, James Mitchell Larner, Jared Weiss, Thomas A. DiPetrillo, Steven J. Feigenberg, Tu Xu, Beibei Hu, Silpa Nuthalapati, Lindsey Rosenwinkel, Lindsey Bensman, Eric Feral Johnson, Mark D. McKee, Everett E. Vokes
Institutions: Dana-Farber Cancer Institute, Duke University, SUNY Upstate Medical University, Wake Forest University, Christiana Care Health System, Christiana Hospital, University of California San Diego, University of Virginia, University of North Carolina at Chapel Hill, Rhode Island Hospital, University of Maryland, Baltimore, AbbVie (United States), University of Chicago
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891728225